Provectus Biopharma (PVCT) Prices $6M Conv. Preferred Stock Offering
Tweet Send to a Friend
Provectus Biopharmaceuticals, Inc. (NYSE: PVCT,) announced the pricing of a "best efforts" public offering of 240,000 shares of Series B ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
